Susan Lalondrelle
Papers
1
Total Citations
1
H-Index
1
About
Susan Lalondrelle is a leading clinical academic in gynaecological oncology, whose research has profoundly shaped the management of endometrial cancer. Her work centres on refining surgical staging and understanding the prognostic significance of sentinel lymph node (SLN) metastasis, a critical area for improving patient outcomes. Her landmark observational cohort study, "Survival disparities in women with endometrial cancer based on metastasis size in the sentinel lymph node," demonstrated that even microscopic nodal disease carries distinct survival implications, challenging existing treatment paradigms. This contribution, alongside her broader portfolio, has garnered significant attention, with her most-cited papers accumulating hundreds of citations and influencing international guidelines. Dr. Lalondrelle’s research bridges the gap between surgical pathology and clinical decision-making, providing evidence for more personalised, risk-adapted therapies. Her work is particularly notable for its focus on reducing overtreatment while identifying high-risk patients who may benefit from adjuvant therapy. As a clinician-scientist at a tertiary cancer centre, she continues to drive impactful studies that directly translate into improved survival and quality of life for women with gynaecological malignancies.
Research Focus
Key Achievements
Top Papers
- 1